And it’s not helpful to always bemoan one’s investment. GNBT is a small company looking to tackle cancer and infectious disease that no big company has done. Triple Negative is an unmet need because big Pharma has failed. Unfortunately GNBT is stuck because the SEC has failed to respond. So they were stuck raising a minimal couple million to self fund just enough to survive. But they didn’t even take any “still” for any self salary. Who here works for years for nothing but hope? I don’t. Yet joe holds CCs knowing there’s distress amongst shareholders. That’s leadership.
(6)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links